Head-to-head · Cost-Efficiency Index
Dollar Dad Club vs Kina
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Dollar Dad Club
Shoppers willing to read past the homepage headline to the product page's actual terms in exchange for named, license-numbered prescribers.
Visit Dollar Dad ClubKina
Cost-first shoppers who want perimenopausal/menopausal women wanting GLP-1 weight management bundled with HRT and other menopause-specific care under one named clinical lead.
Visit KinaThe verdict
Dollar Dad Club and Kina tie on the Cost-Efficiency Index at 69/100, so neither wins outright on the numbers. For most shoppers we'd start with Dollar Dad Club (ranked #98, a hair above #103) — Shoppers willing to read past the homepage headline to the product page's actual terms in exchange for named, license-numbered prescribers. But Kina is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Dollar Dad Club.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Dollar Dad Club | Kina |
|---|---|---|
| Cost-Efficiency Index | 69/100 | 69/100 |
| Semaglutide / mo | $129/mo (all doses, compounded) | $169/mo (all doses, compounded) |
| Tirzepatide / mo | $129/mo | $249/mo (compounded) |
| Semaglutide / yr (modeled) | $1,548 | $2,028 |
| Tirzepatide / yr (modeled) | $1,548 | $2,988 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | Yes | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #98 | #103 |
Dollar Dad Club
69/100Where the value is
- Genuinely names individual licensed prescribers with license numbers by state (Dr. Jeffrey Shellenberger — CA #C160558, MA #290752, VT #042.0015585-COMP; Dr. Marc Serota — RI #MA17024), rarer transparency than most competitors in this batch
- Claims all-50-state coverage
- Both an injectable (semaglutide/tirzepatide, same price) and an oral semaglutide option are offered on one platform
The tradeoffs
- The homepage's headline prices do not reconcile with the product pages' own numbers: '$89/month' injectable matches no total shown anywhere (real totals are $599-$899 for a 6-month plan), and '$149/month' oral is a 3-month-prepay, promo-code, lowest-dose-only rate whose true 1-month price at that dose is $449 — three times the headline
- No compounding pharmacy named, only generic 'leading U.S.-based compounding pharmacies'
Kina
69/100Where the value is
- Names an actual clinical lead (Dr. Shannon Arora, PharmD) tied to a real affiliated practice with an address
- LegitScript badge confirmed with verification link
- Consultation/physician-review fee is bundled into the price rather than charged separately
The tradeoffs
- $169 headline price is a first-month-only discount; true ongoing price is $199/mo
- Not a dedicated GLP-1 company -- weight/GLP-1 is one of six categories on a menopause-focused platform
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.